Identification of Novel Variants in MEN1: A Study Conducted with Four Multiple Endocrine Neoplasia Type 1 Patients
Horm Metab Res DOI: 10.1055/a-1147-1375Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant inherited
endocrine tumor syndrome caused by inactivating variants of the MEN1
gene. The aim of this study is to explore the clinical and genetic
characteristics of four MEN1 patients. We isolated genomic deoxyribonucleic acid
from lymphocytes, parathyroid, and thymic tumoral tissue specimens from the MEN1
patients. All exons of the MEN1 and CDNK1B genes and adjacent
exon-intron sequences were amplified by polymerase chain reaction and
subsequently sequenced. Further, the splice alterations were studied by
sequencing the amplified RT-PCR products for MEN1 cDNA. We identified
four heterozygous MEN1 germline variants: c.564delC, c.1268G>A,
IVS5+5delG, and c.1546_1547insC. Both c.564delC and IVS5+5delG
were novel variants. The impact of the MEN1 splice variant,
IVS5+5delG, was evaluated using bioinformatics and in vitro analyses.
The analyses indicated that this variant resulted in skipping of the neighboring
exon and was disease-causing. Two novel somatic variants, c.249_252delGTCT and
c.313_314insC, were found. Additionally, loss of heterozygosity (LOH) for the
MEN1 locus (IVS5+5delG and c.564delC) was found in tumor
tissue samples from the MEN1 patients, consistent with Knudsonās two-hit
...
Source: Hormone and Metabolic Research - Category: Endocrinology Authors: Hu, Wen-mu Zhang, Qin Huang, Li-hua Mo, Zhao-hui Long, Xiao-dan Yang, You-bo Yang, Wen-jun Liu, Jun Jin, Ping Tags: Endocrine Care Source Type: research
More News: Endocrinology | Genetics | Hormones | Men | Multiple Endocrine Neoplasia | Multiple Endocrine Neoplasia Syndrome | Study